Indian Vaccine Giant Serum Institute Eyes Global Expansion, Mulls Setting Up Its First Manufacturing Plant In Africa
Maharashtra And Its History Of Producing Critical Vaccines
DCGI Approves Study On Mixing Of Covaxin, Covishield Vaccines; Clinical Trial To Begin In Tamil Nadu's Vellore
Serum Institute Likely To Begin Clinical Trial Of Covovax On Children In India From Next Month: Report
Novovax's Covid Vaccine Shows 90 Per Cent Efficacy In Late-Stage Study; Will Be Produced By SII In India As Covovax
Serum Institute Seeks DCGI Nod For License To Manufacture Russian Sputnik V Covid-19 Vaccine In India
Serum Institute’s Covishield Vaccine Produces Antibodies Against B.1.617.1 Variant Of Coronavirus: ICMR Study
India Likely To Face Vaccine Shortage For Next Few Months: Serum Institute’s CEO Adar Poonawalla
Getting Threatening Calls From Very Powerful People, May Start Production In Britain: Adar Poonawalla
1st May D-Day For New Vaccine Policy Seems Dicey; Better Late Than Sorry
Modi Govt Approves Rs 4,500 Crore Assistance For SII And Bharat Biotech To Help Ramp Up Covid Vaccine Production
India Blessed To Have Major Manufacturer Of Global Vaccines Like Serum Institute: World Bank Chief
Knockout Punch To Covid Requires That Most Countries Produce Their Own Jabs With Vaccine Tech
Bolstering India's Credentials As World's Vaccine Hub, 92 Countries Approach Modi Govt For Made-In-India Covid Vaccines
Ahead Of Nationwide Covid-19 Vaccination Drive, Domestic Airlines To Transport 56.5 Lakh Doses Of Vaccine Today
Big Boost For India's Fight Against Covid-19: Serum Institute's Covishield, Bharat Biotech's Covaxin Granted Emergency Use Approval
Boost To India's Fight Against Covid-19: Emergency Use Approval Recommended For SII's Covishield, Bharat Biotech's Covaxin
India To Get Most Of The 40-50 Million Doses Of Covid-19 Vaccine Stockpiled By Serum Institute
Serum Institute Submits Additional Data Sought By India's Drug Regulator For Emergency Approval Of Covishield Vaccine
Serum Institute Aims To Have 100 Million Doses Of Oxford-AstraZeneca's Covid-19 Vaccine Ready By December
ICMR, Serum Institute Complete Enrolment In Phase 3 Clinical Trials For Covid-19 Vaccine 'Covishield'
Government Secures Vaccine Supplies For Half Of The Indian Population From Serum Institute And Novavax: Report
Why Modi Government Is Stingy With Stimulus: The Two Cs Crimping It Are China And Covid-19 Vaccine Rollout Costs
Health Ministry Says It Doesn't Agree With Calculation Of Rs 80,000 Crore For Covid-19 Vaccine Distribution
Serum Institute Asked To Submit Approvals From Data Safety Monitoring Boards of India, UK To Resume Covid Vaccine Trial
Time To Get Tough On Covid Protection: Unlocking India Should Not Mean Unmasking India
After Adverse Reaction In United Kingdom, Serum Institute Halts Indian Trials Of Oxford-AstraZeneca Covid-19 Vaccine
Serum Institute Starts Phase 2, 3 Human Trials Of Oxford-AstraZeneca Covid-19 Vaccine In India
Five Sites In India Ready For Phase 3 Human Trials Of Oxford-AstraZeneca Covid-19 Vaccine
